NCT03539692 Prescreening Protocol to Enroll in Food Allergy Clinical Studies at a Single Site
| NCT ID | NCT03539692 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Food Allergy |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2018-06-10 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2018-06-10 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a protocol for prescreening of participants who would like to be in clinical studies in our Center at Stanford.
Eligibility Criteria
Inclusion Criteria: * Any individual with possible food allergy (as per their clinical history) who is interested in performing the gold standard food challenge for diagnosis. Exclusion Criteria: * Any individual who does not consent * Any individual who is currently taking oral steroids * Any individual with moderate to severe asthma (FEV1\<80%)
Contact & Investigator
Sayantani Sindher, MD
PRINCIPAL INVESTIGATOR
Stanford University, SNP Center for Food Allergy and Asthma Research
Frequently Asked Questions
Who can join the NCT03539692 clinical trial?
This trial is open to participants of all sexes, aged 1 Week or older, up to 90 Years, studying Food Allergy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03539692 currently recruiting?
Yes, NCT03539692 is actively recruiting participants. Contact the research team at snpcenterallergy_inquiry@stanford.edu for enrollment information.
Where is the NCT03539692 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT03539692 clinical trial?
NCT03539692 is sponsored by Stanford University. The principal investigator is Sayantani Sindher, MD at Stanford University, SNP Center for Food Allergy and Asthma Research. The trial plans to enroll 1,000 participants.